Alpha 2.0
Login Register
» Articles » PMID: 36612930

Research on Co-Opetition Mechanism Between Pharmaceutical Enterprises and Third-Party Logistics in Drug Distribution of Medical Community

Overview
Journal Int J Environ Res Public Health
Publisher MDPI
Specialties Environmental Health
Public Health
Date 2023 Jan 8
PMID 36612930
Authors
Zhao Li
Tie Xia
Wanzhi Shen
Sheng Chen
Affiliations
Soon will be listed here.
Abstract

Third-party logistics (3PL) has a relatively perfect distribution system in solving the drug distribution of the medical community and optimizing the distribution efficiency of pharmaceutical enterprises, and it has gradually become an indispensable component of drug distribution. By constructing the co-opetition model of "Pharmaceutical Enterprises-3PL", this paper explores the game strategy choice between pharmaceutical enterprises and 3PL for the solution of drug distribution under the condition of information asymmetry, and it puts forward some suggestions to improve the competition and cooperation mechanism between pharmaceutical enterprises and 3PL in drug distribution in the medical community.

References
1.
Acosta A, Vanegas E, Rovira J, Godman B, Bochenek T . Medicine Shortages: Gaps Between Countries and Global Perspectives. Front Pharmacol. 2019; 10:763. PMC: 6658884. DOI: 10.3389/fphar.2019.00763. View
2.
Liu Z, Lang L, Li L, Zhao Y, Shi L . Evolutionary game analysis on the recycling strategy of household medical device enterprises under government dynamic rewards and punishments. Math Biosci Eng. 2021; 18(5):6434-6451. DOI: 10.3934/mbe.2021320. View
3.
Lawrence J, Hossain N, Jaradat R, Hamilton M . Leveraging a Bayesian network approach to model and analyze supplier vulnerability to severe weather risk: A case study of the U.S. pharmaceutical supply chain following Hurricane Maria. Int J Disaster Risk Reduct. 2020; 49:101607. PMC: 7187851. DOI: 10.1016/j.ijdrr.2020.101607. View
4.
GRABOWSKI H . The effect of pharmacoeconomics on company research and development decisions. Pharmacoeconomics. 1997; 11(5):389-97. DOI: 10.2165/00019053-199711050-00002. View
5.
Sarnola K, Linnolahti J . A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland. Int J Clin Pharm. 2019; 41(4):825-830. PMC: 6677871. DOI: 10.1007/s11096-019-00850-2. View